 CULVER CITY, Calif. EL SEGUNDO, Calif.--BUSINESS WIRE--ImmunityBio, Inc. and NantKwest, Inc. NASDAQ: NK, today announced the completion of their previously announced 100 stock-for-stock merger. This follows the satisfaction of all customary closing conditions, including approval of the merger by a majority of unaffiliated shareholders of NantKwest at its Special Meeting held on March 8, 2021. The combined company will operate under the name ImmunityBio, Inc. ImmunityBio and its share 